Infant Bacterial Therapeutics AB: The Connection Study continues after pre-scheduled Data Monitoring Committee (DMC) review

On September 30, 2021 Infant Bacterial Therapeutics (IBT) announced that the company had reached a key milestone in the development of IBP-9414, after having recruited 600 premature infants to The Connection

Related Keywords

Serbia ,Hungary ,Stockholm ,Sweden ,United Kingdom ,Israel ,Bulgaria ,Poland ,France ,Spain ,Romania , ,Bacterial Therapeutics ,Nasdaq Stockholm ,Small Cap ,Infant Bacterial Therapeutics ,Abuse Regulation ,Securities Markets ,Infant ,Bacterial ,Herapeutics ,Connection ,Study ,Ontinues ,After ,Cheduled ,Data ,Monitoring ,Committee ,Review ,